• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.82% Nasdaq Up0.70%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NMS
    4.87 Down 0.02(0.41%) 4:00PM EDT
    |After Hours : 4.87 Up 0.00 (0.02%) 4:52PM EDT
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Net Income (12,655) (7,147) (10,014) (11,697)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation751  167  137  129  
    Adjustments To Net Income664  809  311  2,238  
    Changes In Accounts Receivables1,204  (2,005)(110)(1,257)
    Changes In Liabilities1,639  (1,148)3,299  1,202  
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities448  (1,155)(3,381)374  
    Total Cash Flow From Operating Activities (7,967) (10,486) (9,758) (9,011)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(607)(96)(41)(180)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities113  (6,200)29  15  
    Total Cash Flows From Investing Activities (494) (6,296) (12) (165)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock -  430  899  55  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities -   430   899   55  
    Effect Of Exchange Rate Changes33  17   -   -  
    Change In Cash and Cash Equivalents (8,428) (16,335) (8,871) (9,121)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.